Asimadoline (EMD-61753) is a drug which acts as a peripherally selective κ-opioid agonist. Because of its poor ability to cross the blood–brain barrier asimadoline lacks the psychotomimetic effects of centrally acting kappa agonists and consequently has more potential for medical use and has been researched as a possible treatment for irritable bowel syndrome with reasonable efficacy seen in clinical trials.
This page contains content from the copyrighted Wikipedia article "Asimadoline"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
